Quantification of delineation errors of the gross tumor volume on magnetic resonance imaging in uterine cervical cancer using pathology data and deformation correction

Abstract Background. To safely optimize target volumes using magnetic resonance imaging (MRI) for uterine cervical cancer radiation therapy, MRI findings need to be validated. The aim of this study was to correlate pre-operatively acquired MRI and surgical specimen imaging for uterine cervical cancer patients using deformable image registration and quantify gross tumor volume (GTV) delineation discrepancies. Material and methods. For 16 retrospectively selected early-stage uterine cervical cancer patients, the cervix-uterus structure, uterine cavity and the GTV were delineated on 2D pathology photos after macroscopic intersection and corresponding pre-operatively acquired T2-weighted 2D sagittal MR images. Segmentations of pathology photos and MR images were simultaneously registered using a three-step multi-image registration strategy. The registration outcome was evaluated by the Dice similarity coefficient (DSC) and the surface distance error (SDE). In addition, GTV expansions within the cervix-uterus structure needed to obtain 95% GTV coverage were determined. Results. After three-step multi-image registration, the median DSC and median SDE were 0.98 and 0.4 mm (cervix-uterus) and 0.90 and 0.4 mm (uterine cavity), respectively. The average SDE around the GTV was 0.7 mm (range, 0.1 mm – 2.6 mm). An underestimation of MRI-based GTV delineations was found when no margin was applied, indicated by a mean GTV coverage of 61%. To obtain 95% GTV coverage for 90% of the patients, a minimum 12.0 mm margin around MRI-based GTVs was needed. Conclusion. The presented three-step multi-image registration strategy was suitable and accurate to correlate MRI and pathology data for uterine cervical cancer patients. To cover the pathology-based GTV, a margin of at least 12.0 mm around GTV delineations on T2-weighted MRI is needed.

[1]  M. J. van de Vijver,et al.  Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: systematic review of diagnostic test accuracy. , 2013, European journal of radiology.

[2]  Yongchun Zhou,et al.  Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer , 2013, OncoTargets and therapy.

[3]  M S Hoogeman,et al.  Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. , 2012, International journal of radiation oncology, biology, physics.

[4]  Cornelis A T van den Berg,et al.  Validation of imaging with pathology in laryngeal cancer: accuracy of the registration methodology. , 2011, International journal of radiation oncology, biology, physics.

[5]  Colleen A. Lawton Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer , 2012 .

[6]  Steve B. Jiang,et al.  Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. , 2011, International journal of radiation oncology, biology, physics.

[7]  C. Yashar,et al.  Evaluation of intra- and inter-fraction movement of the cervix during intensity modulated radiation therapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  E. Sala,et al.  The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. , 2010, European journal of radiology.

[9]  H. Hricak,et al.  Semi‐automatic deformable registration of prostate MR images to pathological slices , 2010, Journal of Magnetic Resonance Imaging.

[10]  J. Tierney,et al.  Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  Christian Kirisits,et al.  Adaptive management of cervical cancer radiotherapy. , 2010, Seminars in radiation oncology.

[12]  Marco van Vulpen,et al.  Validation of functional imaging with pathology for tumor delineation in the prostate. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[14]  Christian Kirisits,et al.  Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Hyunjin Park,et al.  Registration methodology for histological sections and in vivo imaging of human prostate. , 2008, Academic radiology.

[16]  H. Hricak,et al.  Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  I. Barillot,et al.  The use of MRI in planning radiotherapy for gynaecological tumours , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.

[18]  Christian Kirisits,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Herk Errors and margins in radiotherapy. , 2004 .

[21]  Patrick M M Bossuyt,et al.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.

[22]  A. Beddoe,et al.  The effects of delays in radiotherapy treatment on tumour control. , 2003, Physics in medicine and biology.

[23]  N. deSouza,et al.  High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings. , 1996, AJR. American journal of roentgenology.

[24]  H. Hricak,et al.  Cervical Carcinoma: Computed Tomography and Magnetic Resonance Imaging for Preoperative Staging , 1995, Obstetrics and gynecology.